Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Avg patent value: 6.49 M | |||
2 | Avg patent value: 6.49 M | |||
3 | Avg patent value: 3.53 M | |||
4 | Avg patent value: 3.53 M | |||
5 | Avg patent value: 0 |
Top 5 Key Players companies in Dimethyl fumarate
by Highest Patent Value in the Switzerland in 2018
The Dimethyl fumarate top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Dimethyl fumarate Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Dimethyl fumarate (DMF) is the methyl ester of fumaric acid and is named after the earth smoke plant (Fumaria officinalis). DMF combined with three other fumaric acid esters (FAEs) is solely licensed in Germany as an oral therapy for psoriasis (trade name Fumaderm®). Since 2013, it has been used to treat adults with relapsing multiple sclerosis (trade name Tecfidera®). In 2017, a new oral formulation of DMF (trade name Skilarence®) was approved by the European Medicines Agency (EMA) for use in Europe as a treatment for moderate-to-severe plaque psoriasis. DMF is thought to have immunomodulatory properties without causing significant immunosuppression.
Page generation time:
May 10 2025